Cascadian Therapeutics Overview
- Year Founded
-
1985
- Status
-
Acquired/Merged
- Employees
-
71
- Latest Deal Type
-
M&A
- Financing Rounds
-
9
- Investments
-
4
Cascadian Therapeutics General Information
Description
Provider of clinical-stage biopharmaceutical services intended to develop and commercialize novel targeted compounds. The company's clinical-stage biopharmaceutical services include developing cancer vaccines designed to stimulate the immune system to attack cancer cells, while its small molecule compounds are designed to inhibit the activity of specific cancer-related proteins.
Contact Information
Website
www.cascadianrx.comCorporate Office
- 3101 Western Avenue
- Suite 600
- Seattle, WA 98121
- United States
Corporate Office
- 3101 Western Avenue
- Suite 600
- Seattle, WA 98121
- United States
Cascadian Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cascadian Therapeutics Comparisons
Industry
Financing
Details
Cascadian Therapeutics Competitors (68)
One of Cascadian Therapeutics’s 68 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Circle Pharma | Venture Capital-Backed | South San Francisco, CA | ||||
| Innovimmune Biotherapeutics | Accelerator/Incubator Backed | New York, NY | ||||
| Carina Biotech | Venture Capital-Backed | Mawson Lakes, Australia | ||||
| Adimab | Venture Capital-Backed | Lebanon, NH |
Cascadian Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cascadian Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cascadian Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cascadian Therapeutics Investments & Acquisitions (4)
Cascadian Therapeutics’s most recent deal was a Merger/Acquisition with Alpine Biosciences for . The deal was made on 11-Aug-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alpine Biosciences | 11-Aug-2014 | Merger/Acquisition | Biotechnology | ||
| ProlX Pharmaceuticals | 30-Oct-2006 | Merger/Acquisition | Drug Discovery | ||
| Anthera Pharmaceuticals | 21-Apr-2005 | Early Stage VC | Pharmaceuticals | ||
| OncoTherapeutics | 01-Sep-1995 | Merger/Acquisition | BPO/Outsource Services |
Cascadian Therapeutics Exits (2)
Cascadian Therapeutics’s most recent exit was on 21-Apr-2005 from Anthera Pharmaceuticals. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Anthera Pharmaceuticals | 21-Apr-2005 | Completed |
|
||
| OncoTherapeutics | 01-Sep-1995 | Merger/Acquisition | Completed |
Cascadian Therapeutics Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Oncothyreon Canada | Edmonton, Canada | 2007 | |
| ProlX Pharmaceuticals | Tucson, AZ | 1996 |
Cascadian Therapeutics FAQs
-
When was Cascadian Therapeutics founded?
Cascadian Therapeutics was founded in 1985.
-
Where is Cascadian Therapeutics headquartered?
Cascadian Therapeutics is headquartered in Seattle, WA.
-
What is the size of Cascadian Therapeutics?
Cascadian Therapeutics has 71 total employees.
-
What industry is Cascadian Therapeutics in?
Cascadian Therapeutics’s primary industry is Drug Discovery.
-
Is Cascadian Therapeutics a private or public company?
Cascadian Therapeutics is a Private company.
-
What is the current valuation of Cascadian Therapeutics?
The current valuation of Cascadian Therapeutics is .
-
What is Cascadian Therapeutics’s current revenue?
The current revenue for Cascadian Therapeutics is .
-
How much funding has Cascadian Therapeutics raised over time?
Cascadian Therapeutics has raised $209M.
-
Who are Cascadian Therapeutics’s investors?
BVF Partners, Cranshire Capital Advisors, Heights Capital, Kearny Venture Partners, and New Enterprise Associates have invested in Cascadian Therapeutics.
-
Who are Cascadian Therapeutics’s competitors?
CytomX Therapeutics, Circle Pharma, Innovimmune Biotherapeutics, Carina Biotech, and Adimab are some of the 68 competitors of Cascadian Therapeutics.
-
When was Cascadian Therapeutics acquired?
Cascadian Therapeutics was acquired on 09-Mar-2018.
-
Who acquired Cascadian Therapeutics?
Cascadian Therapeutics was acquired by Seagen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
